California Independent Diagnostic Testing Facility and Owner Agree to Voluntary Exclusion
On September 8, 2017, Olive Sleep & EEG, Inc., an independent diagnostic testing facility, and Mariam Unjughulyan, its owner, (collectively, "Olive Sleep") agreed to be excluded for a period of five years under 42 U.S.C. § 1320a-7(b)(7). OIG's investigation revealed that Olive Sleep submitted claims for nerve conduction studies that are considered screening exams and not covered by Medicare in violation of a Local Coverage Determination governing the medical necessity of such studies. OIG's Office of Audit Services and Office of Counsel to the Inspector General, represented by Senior Counsels Geoffrey Hymans and Kenneth Kraft, collaborated to achieve this resolution.
- Date:September 8, 2017
- CMP and Affirmative Exclusions